Public Comment at the COVID vaccine FDA Advisory Committee Meeting February 26, 2021
Public Deposited- Last Modified
- February 23, 2021
- Creator
-
Dasgupta, Nabarun
- ORCID: https://orcid.org/0000-0002-4098-605X
- Affiliation: Gillings School of Global Public Health
- Other Affiliation: Injury Prevention Research Center
-
Lazard, Allison
- ORCID: http://orcid.org/0000-0002-2502-2850
- Affiliation: Hussman School of Journalism and Media
-
Brownstein, John S.
- ORCID: http://orcid.org/0000-0001-8568-5317
- Other Affiliation: Boston Children's Hospital, Harvard Medical School
- Abstract
- Public comments on COVID-19 vaccine side effect surveillance at the US Food and Drug Administration (FDA) Advisory Committee on February 26, 2021. The Janssen (Johnson & Johnson) vaccine was discussed at this meeting. We declare no conflicts of interest.
- Date of publication
- February 26, 2021
- Keyword
- Subject
- DOI
- Resource type
- Rights statement
- In Copyright
- License
- CC0 1.0 Universal
- Language
- Location
- Chapel Hill, North Carolina, United States
Relations
- Parents:
- In Collection:
This work has no parents.
Items
| Thumbnail | Title | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|
|
|
Dasgupta_-_OPC_Feb_26__2021.pptx | 2021-02-23 | Public | Download |